Mechanistic Insights of Premature Ventricular Contractions-induced Cardiomyopathy
Mechanistic Insights of Premature Ventricular Contractions-induced Cardiomyopathy
批准号:
9922678
负责人:
Jose Francisco Huizar
金额:
$65.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-15 至 2024-04-30
关键词:
AcuteAdmission activityAnimal ModelAnimalsBiopsyCalpainCardiacCardiomyopathiesCaringChemosensitizationChronicClinicalCoupledCouplingDevelopmentEtiologyEvaluationExposure toFinancial HardshipFrequenciesFunctional disorderFutureHealthcareHeartHeart failureIceImpairmentImplantLeadMAP Kinase GeneMechanicsMediator of activation proteinMethodsMicroRNAsMolecularMolecular StructurePacemakersPathway interactionsPatientsPhasePreventionProteinsRandomizedRecoveryResearchRiskRoleSERCA2aScaffolding ProteinSecondary toSeveritiesStructural ProteinStructureTestingTimeVentricularVentricular Premature Complexesclinical phenotypehemodynamicshigh riskimproved functioninginsightjunctophilinmolecular phenotypemortalityphospholambanplacebo groupprematurepreventresilienceresponserestorationtheories
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background. Frequent premature ventricular contractions (PVCs) can cause LV dysfunction (CM), referred to
as PVC-cardiomyopathy (PVC-CM). The mechanism responsible and the impact of PVC coupling interval
(prematurity) are unclear. Suspected triggers are post-extrasystolic potentiation and LV dyssynchrony.
Hypotheses. Our four working hypotheses are: 1) Post-extrasystolic potentiation, associated with PVCs, is a
key trigger responsible for PVC-CM. LV dysfunction (Aim 1), impaired EC coupling and dyad remodeling (Aim
2) are greater in early- rather than late-coupled PVCs since this phenomenon is more prominent in early-
rather than late-coupled PVCs; 2) Impaired EC coupling in PVC-CM is due to changes in JPH-2 and Cav1.2
pathways (Fig.1); 3) Early changes in dyad, JPH-2 and Cav1.2 pathways precede the development of this CM
and the recovery of LV function after PVC cessation, providing evidence that these changes are a primary
cause of CM (Aim 2); and 4) Baseline clinical and structural / molecular phenotype can identify those animals
that will develop PVC-CM when exposed to 33% PVC burden.
Aim 1. Evaluate the impact of post-extrasystolic potentiation and PVC coupling interval in the development of
LV dysfunction associated with chronic exposure to frequent PVCs (PVC-CM).
Aim 2. Determine the temporal structural and molecular changes responsible for decrease in Ca2+ release and
Junctophylin-2, and their role on the pathophysiology of PVC-CM and recovery upon PVC cessation.
Aim 3. Identify baseline echocardiographic, hemodynamic and molecular features that can predict the
development of, or resilience to PVC-CM despite identical ventricular ectopy.
Methods. 56 animals will undergo pacemaker implant to reproduce frequent ventricular ectopy (PVCs). They
will be randomized to one of 4 groups: 1) early-coupled 50% PVCs (n=13), 2) late-coupled 50% PVCs (n=13),
3) early-coupled PVCs 33% PVCs (n=18), or 4) control (n=12) groups. At the end of a 12-week PVC period, a
recovery phase (disabling PVCs) will be allowed in 6 animals of each group exposed to 50% burden and sham
group (Fig. 6). Serial cardiac evaluation and biopsies will allow us to assess LV function, dyad structure, Ca2+
transients (EC coupling), changes in JPH-2 and Cav1.2 expression, function and distribution and their
mediators at baseline and different time points of PVC-CM in all groups.
Significance. This study will: 1) provide an understanding of the role of post-extrasystolic potentiation and LV
dyssynchrony in the mechanism of PVC-CM; 2) assess the impact of PVC coupling interval in the development
or severity of PVC-CM, 3) identify molecular mechanisms behind impaired EC coupling in PVC-CM and 4)
identify baseline clinical and molecular phenotypes that distinguish patients at risk to develop PVC-CM.
Understanding the mechanism of PVC-CM will help us to identify high-risk patients for development of PVC-
CM, but most importantly find future targets to prevent and treat subjects with PVC-CM.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.jacep.2020.08.028
发表时间:
2021-03
期刊:
JACC-CLINICAL ELECTROPHYSIOLOGY
影响因子:
7
作者:
[Huizar, Jose F., Fisher, Susan G., Ramsey, Frederick, V, Kaszala, Karoly, Tan, Alex Y., Moore, Hans, Koneru, Jayanthi N., Kron, Jordana, Padala, Santosh K., Ellenbogen, Kenneth A., Singh, Steven N.]
通讯作者:
Singh, Steven N.
Left ventricular dyssynchrony as marker of early dysfunction in premature ventricular contraction-induced cardiomyopathy.
左心室异位障碍作为早期功能障碍的标志性,在室性过早收缩引起的心肌病中。
DOI:
10.3389/fcvm.2022.978341
发表时间:
2022
期刊:
FRONTIERS IN CARDIOVASCULAR MEDICINE
影响因子:
3.6
作者:
[Kowlgi, Gurukripa N., Tan, Alex Y., Kaszala, Karoly, Kontos, Michael C., Lozano, Pedro, Ellenbogen, Kenneth A., Huizar, Jose F.]
通讯作者:
Huizar, Jose F.
DOI:
10.1016/j.hroo.2020.12.021
发表时间:
2021-03
期刊:
Heart rhythm O2
影响因子:
--
作者:
[Torrado J, Kowlgi GN, Ramirez RJ, Balderas-Villalobos J, Jovin D, Parker C, Om E, Airapetov S, Kaszala K, Tan AY, Ellenbogen KA, Huizar JF]
通讯作者:
Huizar JF
Research-Dedicated Magnetic Resonance Imaging at McGuire VA Medical Center
-
批准号:10177717
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Jose Francisco Huizar
-
依托单位:
Validation of Premature Ventricular Contraction-induced Cardiomyopathy on a Swine Model
-
批准号:9892561
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Jose Francisco Huizar
-
依托单位:
LV dyssynchrony and fibroblast activation in PVC-induced Cardiomyopathy
-
批准号:10669334
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Jose Francisco Huizar
-
依托单位:
Novel in situ custom biodegradable drug-eluting stents for endovascular surgery
-
批准号:10663244
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Jose Francisco Huizar
-
依托单位:
Validation of Premature Ventricular Contraction-induced Cardiomyopathy on a Swine Model
-
批准号:10664914
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Jose Francisco Huizar
-
依托单位: